Comparing two laser treatments for open-angle glaucoma eye pressure
Compares a newer automated laser method with standard laser treatment in adults with open-angle glaucoma.
Plain-language title generated from the registry record
Registry title: Direct vs. Conventional SLT in Open-Angle Glaucoma: A RCT
Key facts
- Where
- Charleston, United StatesSee the site
Where in United States
- MUSC Health West Ophthalmology ClinicCharleston, United StatesNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Medical University of South Carolina
- Trial code
- NCT06925477
- Record updated
- 14 September 2026
- Original description
This study compares two laser treatments for open-angle glaucoma: Selective Laser Trabeculoplasty (SLT) and Direct Selective Laser Trabeculoplasty (DSLT). SLT is a widely used procedure that requires a manual technique with a goniolens, while DSLT is a new, automated, non-contact method using the Eagle system. The study will evaluate whether DSLT is as effective as SLT in reducing intraocular pressure (IOP). Participants will be randomly assigned to receive either treatment and will be monitored over 12 months to assess changes in IOP, medication use, and safety outcomes. The goal is to determine if the simpler DSLT procedure can provide similar results to SLT, potentially improving patient comfort and access to glaucoma care.Read full original descriptionShow less
Direct Selective Laser Trabeculoplasty (DSLT) and Selective Laser Trabeculoplasty (SLT) in Reducing Intraocular Pressure in Open-Angle Glaucoma
This study compares two laser treatments for open-angle glaucoma: Selective Laser Trabeculoplasty (SLT) and Direct Selective Laser Trabeculoplasty (DSLT). SLT is a widely used procedure that requires a manual technique with a goniolens, while DSLT is a new, automated, non-contact method using the Eagle system. The study will evaluate whether DSLT is as effective as SLT in reducing intraocular pressure (IOP). Participants will be randomly assigned to receive either treatment and will be monitored over 12 months to assess changes in IOP, medication use, and safety outcomes. The goal is to determine if the simpler DSLT procedure can provide similar results to SLT, potentially improving patient comfort and access to glaucoma care.
Inclusion: Age ≥18 years; Diagnosed with OAG (including exfoliative/pigmentary glaucoma) or OHT; Gonioscopically visible scleral spur for 360 degrees; Ability to provide informed consent; In good health, without prior laser trabeculoplasty, with decision to treat made by an ophthalmologist on the basis of risk profile, patient preference, or both; Each eye with one of the following qualifying diagnoses (diagnoses may differ between eyes):; High-risk ocular hypertension (OHT): IOP > 21 mmHg without glaucomatous optic neuropathy (excavation, diffuse or focal thinning or notching of the neuroretinal rim, visible nerve fiber layer defects, or asymmetry of the vertical cup-to-disc ratio of >0.2 between eyes) [enrollment of trial participants with High-risk OHT will be capped at 25% of total enrollment]; Mild primary open-angle glaucoma: glaucomatous optic neuropathy, visual field mean deviation >-6.0 dB with no points in the central 5° <15 dB; Moderate primary open-angle glaucoma: glaucomatous optic neuropathy, visual field mean deviation -6.0 dB to >-12 dB and no more than 1 central 5° point <15 dB.
Exclusion: Any intraocular surgical procedure within the past 6 months in either eye; Any prior laser trabeculoplasty, including ALT, MLT and SLT; Advanced POAG in either eye; Glaucoma other than OAG (including pigmentary and pseudoexfoliation glaucoma) in either eye; Mean IOP > 35 mmHg at either the screening or baseline visit in either eye; Narrow or closed angle (Shaffer Grade 0, 1, or 2) in either eye; Contraindications to SLT, brimonidine, apraclonidine, or any other study intervention; Any corneal pathology that would preclude accurate assessment of IOP by Goldmann tonometry in either eye; Inability to attend all scheduled study visits; Pregnancy or plan to become pregnant in the next 1 year.